Add Up The Parts: IAK Could Be Worth $148
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 16 2025
0mins
Source: NASDAQ.COM
ETF Analysis: The iShares U.S. Insurance ETF (IAK) has an implied analyst target price of $147.87, indicating an 11.68% upside from its current trading price of $132.40. Notable underlying holdings with significant upside include Kemper Corp, MetLife Inc, and Genworth Financial.
Investor Considerations: Analysts' target prices may reflect optimism or could be outdated, prompting the need for further research by investors to assess the validity of these targets in light of recent developments in the companies and industry.
Analyst Views on GNW
Wall Street analysts forecast GNW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GNW is 10.00 USD with a low forecast of 10.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 8.270
Low
10.00
Averages
10.00
High
10.00
Current: 8.270
Low
10.00
Averages
10.00
High
10.00
About GNW
Genworth Financial, Inc., through its principal insurance subsidiaries, offers mortgage and long-term care insurance products. The Company is the holding company of Enact Holdings, Inc (Enact Holdings). The Company operates through three segments: Enact, Long-Term Care Insurance, and Life and Annuities. Through Enact Holdings and its mortgage insurance subsidiaries, it provides private mortgage insurance products and services in the United States and operates in all 50 states and the District of Columbia. The Enact segment is engaged in the business of writing and assuming residential mortgage guaranty insurance. The Long-Term Care Insurance segment includes long-term care insurance products. The Life and Annuities segment includes traditional and non-traditional life insurance (term, universal and term universal life insurance as well as corporate-owned life insurance and funding agreements), fixed annuities and variable annuities.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.








